Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Price:
27.21 USD
-1.27%
Market Closed
Updated:
May 9, 2024
Arcturus Therapeutics Holdings Inc
Pre-Tax Income
|
Arcturus Therapeutics Holdings Inc
Pre-Tax Income Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
|
Pre-Tax Income
-$27.9m
|
CAGR 3-Years
27%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-10%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Pre-Tax Income
$6.3B
|
CAGR 3-Years
23%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Pre-Tax Income
$1.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-16%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Pre-Tax Income
$4.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Pre-Tax Income
$4.4B
|
CAGR 3-Years
12%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Pre-Tax Income
$4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
18%
|
See Also
What is Arcturus Therapeutics Holdings Inc's Pre-Tax Income?
Pre-Tax Income
-27.9m
USD
-27.9m
USD
Based on the financial report for Dec 31, 2023, Arcturus Therapeutics Holdings Inc's Pre-Tax Income amounts to -27.9m USD.
What is Arcturus Therapeutics Holdings Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-10%
-10%
The average annual Pre-Tax Income growth rates for Arcturus Therapeutics Holdings Inc have been 27% over the past three years , -5% over the past five years , and -10% over the past ten years .
You don't have any saved screeners yet
